Taxus Cardium Pharmaceuticals Group Inc (CRXM)

[docj]

EXPLANATORY NOTE TO 10-K/A



This Amendment No. 1 on Form 10-K/A (“Amendment”) is being filed to reflect that the Company’s predecessor auditor did not reissue its audit report for the financial statements for the year ended December 31, 2019, and the Company did not include the audit report in the Annual Report on Form 10-K filed with the Commission on March 30, 2022 (the “10-K”). The audit report issued by the auditor for the financial statements for the year ended December 31, 2020 has been revised, a note has been added to the header of the financial statements, and an additional Note 12 has been added to the footnotes of the financial statements. Otherwise, all other information in this Amendment is the same as the original 10-K. The Company plans to file a further amendment to the 10-K to include an audit report for the financial statements for the year ended December 31, 2019.